SB Life Science Equity Management Overview

  • Investor Type
  • Venture Capital

  • Status
  • Inactive

  • Investments
  • 12

  • Exits
  • 11

Exits

SB Life Science Equity Management General Information

Company Description

SB Life Science Equity Management was a California-based venture capital firm. The firm invested in companies at any stage of development, including start up, early stage, development, expansion and mezzanine. It invested in life science and biomedical sector, particularly in the drug discovery, drug development and medical devices companies.

Business Details

Year Founded
2001
Investor Status
Out of Business
Primary Investor Type
Venture Capital
Corporate Office
  • 2625 Middlefield Road
  • Suite 750
  • Palo Alto, CA 94306
  • United States

SB Life Science Equity Management Investments (12)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Zyomyx 29-Jan-2010 Later Stage VC 00000 Diagnostic Equipment Out of Business
Calypso Medical 24-Sep-2009 00000 00000 0000 Diagnostic Equipment Generating Revenue
Gemin X Pharmaceuticals 01-Jul-2008 00000 00000 0000 Pharmaceuticals Clinical Trials - Phase 2
U-Systems 15-Jun-2007 00000 00000 000.00 Diagnostic Equipment Generating Revenue
CircuLite 23-Apr-2007 00000 00000 000.00 Surgical Devices Generating Revenue
Optimer Pharmaceuticals 30-Nov-2005 00000 00000 000.00 Pharmaceuticals Generating Revenue
Perlegen 08-Mar-2005 00000 00000 0000 Pharmaceuticals Bankruptcy: Liquidation
Kadmus Pharmaceuticals 08-Jan-2004 00000 00000 0000 Pharmaceuticals Generating Revenue
Perlegen 04-Mar-2003 Later Stage VC 000.00 Pharmaceuticals Bankruptcy: Liquidation
NuGEN 04-Dec-2001 Early Stage VC 000.00 Other Pharmaceuticals and Biotechnology Profitable
You’re viewing 10 of 12 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SB Life Science Equity Management Exits (11)

Company Name Exit Date Exit Type Exit Size
Intarcia 01-Nov-2020 Bankruptcy: Liquidation
NuGEN 31-Aug-2018 000000000000000000 000.00
Zyomyx 01-Oct-2014 000 00 00000000
CircuLite 01-Dec-2013 000000000000000000 0000
Optimer Pharmaceuticals 24-Oct-2013 000000000000000000 00000
U-Systems 09-Nov-2012 000000000000000000
Calypso Medical 19-Sep-2011 000000000000000000 000.00
Gemin X Pharmaceuticals 01-Apr-2011 000000000000000000 00000
Perlegen 31-Dec-2009 Bankruptcy: Liquidation
Kadmus Pharmaceuticals 26-Jun-2007 Merger/Acquisition
You’re viewing 10 of 11 exits. Get the full list »

SB Life Science Equity Management Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

SB Life Science Equity Management FAQs

  • What is SB Life Science Equity Management?

    SB Life Science Equity Management was a California-based venture capital firm.

  • When was SB Life Science Equity Management founded?

    SB Life Science Equity Management was founded in 2001.

  • Where is SB Life Science Equity Management headquartered?

    SB Life Science Equity Management is headquartered in Palo Alto, CA.

  • How many investments has SB Life Science Equity Management made?

    SB Life Science Equity Management has made 12 investments.

  • What has SB Life Science Equity Management invested in?

    SB Life Science Equity Management has made numerous investments in companies like Zyomyx, Calypso Medical, and Gemin X Pharmaceuticals within the Diagnostic Equipment and Pharmaceuticals industries.

  • What has SB Life Science Equity Management invested in recently?

    SB Life Science Equity Management's latest investment was on 29-Jan-2010 in Zyomyx, a company within the Diagnostic Equipment industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »